Loading
Fluoroquinolone·Infectious Diseases - Other Antibiotics
Severe Community Acquired Pneumonia (CAP), complicated intra-abdominal infections, pelvic inflammatory disease
Max Dose
400 mg/day
Half-life
12 h
Tendon Rupture
CRITICAL
UTI Treatment
USELESS
Overview
The 'Respiratory Fluoroquinolone'. Uniquely potent against Streptococcus pneumoniae and deep anaerobes. Completely bypasses the kidneys, making it useless for UTIs but incredibly safe in renal failure.
Maximum Dose
Max 400 mg/day.
Clinical Focus
Black Box warnings for Achilles tendon rupture and aortic dissection. Do not use for mild infections.
Bottom Line
Moxifloxacin is a respiratory fluoroquinolone covering atypicals and anaerobes without renal dose adjustment, but has the highest QTc prolongation risk of all fluoroquinolones and carries tendon rupture risk.
Brand Names
Avelox
Oral Routes
Tablets (400 mg).
Parenteral
Pre-mixed infusion bags for IV use.
Prescribing & PBS
Authority Required (PBS).
Primary
Severe Community Acquired Pneumonia (CAP), complicated intra-abdominal infections, pelvic inflammatory disease.
Clinical Place
A powerful monotherapy option for severe pneumonia in penicillin-allergic patients, as it covers typicals, atypicals, and anaerobes in a single pill.